PUMA BIOTECHNOLOGY, INC. Payments for Capital Improvements
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Payments for Capital Improvements of $170.00 thousand for the 12-month period ending 2018-12-31, per its 10-K filed 2021-03-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForCapitalImprovements · last filed 2021-03-01
- PUMA BIOTECHNOLOGY, INC. payments for capital improvements for the quarter ending 2016-12-31 was $0.00.
- PUMA BIOTECHNOLOGY, INC. payments for capital improvements for the quarter ending 2016-09-30 was $0.00.
- PUMA BIOTECHNOLOGY, INC. payments for capital improvements for the quarter ending 2015-12-31 was $0.00, a 100.00% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. payments for capital improvements for the quarter ending 2015-09-30 was $0.00.
- PUMA BIOTECHNOLOGY, INC. payments for capital improvements for fiscal 2018 was $170.00K.
- PUMA BIOTECHNOLOGY, INC. payments for capital improvements for fiscal 2016 was $3.00M, a 1574.30% increase from fiscal 2015.
- PUMA BIOTECHNOLOGY, INC. payments for capital improvements for fiscal 2015 was $179.00K, a 6.77% decline from fiscal 2014.
- PUMA BIOTECHNOLOGY, INC. payments for capital improvements for fiscal 2014 was $192.00K, a 4700.00% increase from fiscal 2013.
| Period end | Payments for Capital Improvements 3 month | Payments for Capital Improvements 3 month as first filed | Payments for Capital Improvements 6 month | Payments for Capital Improvements 6 month as first filed | Payments for Capital Improvements 9 month | Payments for Capital Improvements 9 month as first filed | Payments for Capital Improvements 12 month | Payments for Capital Improvements 12 month as first filed | Payments for Capital Improvements 16 month | Payments for Capital Improvements 18 month | Payments for Capital Improvements 21 month | Payments for Capital Improvements 25 month | Payments for Capital Improvements 27 month | Payments for Capital Improvements 30 month | Payments for Capital Improvements 33 month | Payments for Capital Improvements 36 month | Payments for Capital Improvements 39 month | Payments for Capital Improvements 42 month | Payments for Capital Improvements 45 month | Payments for Capital Improvements 48 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | $170.00K 10-K · filed 2021-03-01 | |||||||||||||||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $0.00 derived: sum of 2 quarters · filed 2019-03-01 | $3.00M 10-K · filed 2019-03-01 | |||||||||||||||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $3.00M 10-Q · filed 2017-11-09 | ||||||||||||||||||
| 2016-06-30 | $3.00M 10-Q · filed 2017-08-09 | |||||||||||||||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $0.00 derived: sum of 2 quarters · filed 2018-03-09 | $0.00 derived: sum of 3 quarters · filed 2018-03-09 | $179.00K 10-K · filed 2018-03-09 | ||||||||||||||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | $179.00K 10-Q · filed 2016-11-09 | $261.00K derived: sum of 4 quarters · filed 2017-03-01 | ||||||||||||||||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $179.00K 10-Q · filed 2016-08-09 | $261.00K derived: sum of 3 quarters · filed 2017-03-01 | $261.00K derived: sum of 4 quarters · filed 2017-03-01 | ||||||||||||||||
| 2015-03-31 | $179.00K 10-Q · filed 2016-05-10 | $261.00K derived: sum of 2 quarters · filed 2017-03-01 | $261.00K derived: sum of 3 quarters · filed 2017-03-01 | $367.00K derived: sum of 4 quarters · filed 2017-03-01 | ||||||||||||||||
| 2014-12-31 | $82.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $82.00K derived: sum of 2 quarters · filed 2017-03-01 | $188.00K derived: sum of 3 quarters · filed 2017-03-01 | $192.00K 10-K · filed 2017-03-01 | ||||||||||||||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $106.00K derived: sum of 2 quarters · filed 2015-11-09 | $110.00K 10-Q · filed 2015-11-09 | $111.00K derived: sum of 4 quarters · filed 2016-02-29 | $1.02M 10-Q · filed 2014-11-10 | |||||||||||||||
| 2014-06-30 | $106.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $110.00K 10-Q · filed 2015-08-10 | $111.00K derived: sum of 3 quarters · filed 2016-02-29 | $110.00K derived: sum of 4 quarters · filed 2016-02-29 | $1.02M 10-Q · filed 2014-08-11 | |||||||||||||||
| 2014-03-31 | $4.00K 10-Q · filed 2015-05-11 | $5.00K derived: sum of 2 quarters · filed 2016-02-29 | $4.00K derived: sum of 3 quarters · filed 2016-02-29 | $8.00K derived: sum of 4 quarters · filed 2016-02-29 | $918.00K 10-Q · filed 2014-05-12 | |||||||||||||||
| 2013-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $0.00 derived: sum of 2 quarters · filed 2016-02-29 | $4.00K derived: sum of 3 quarters · filed 2016-02-29 | $4.00K 10-K · filed 2016-02-29 | $914.00K 10-K · filed 2014-03-03 | |||||||||||||||
| 2013-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $3.00K derived: sum of 2 quarters · filed 2014-11-10 | $3.00K 10-Q · filed 2014-11-10 | $238.00K derived: sum of 4 quarters · filed 2015-03-02 | $913.00K 10-Q · filed 2013-11-12 | |||||||||||||||
| 2013-06-30 | $4.00K derived: 10-Q 33 month − 10-Q 30 month · filed 2013-08-06 | $4.00K 10-Q · filed 2014-08-11 | $239.00K derived: sum of 3 quarters · filed 2015-03-02 | $239.00K derived: sum of 4 quarters · filed 2015-03-02 | $914.00K 10-Q · filed 2013-08-06 | |||||||||||||||
| 2013-03-31 | $0.00 derived: 10-Q 30 month − 10-K 27 month · filed 2013-05-09 | $235.00K derived: sum of 2 quarters · filed 2015-03-02 | $235.00K derived: sum of 3 quarters · filed 2015-03-02 | $235.00K derived: sum of 4 quarters · filed 2015-03-02 | $910.00K 10-Q · filed 2013-05-09 | |||||||||||||||
| 2012-12-31 | $235.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $235.00K derived: sum of 2 quarters · filed 2015-03-02 | $235.00K derived: sum of 3 quarters · filed 2015-03-02 | $471.00K 10-K · filed 2015-03-02 | $910.00K 10-K · filed 2013-04-01 | |||||||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $236.00K 10-Q · filed 2013-11-12 | $236.53K 10-Q · filed 2012-11-14 | $675.95K 10-Q · filed 2012-11-14 | |||||||||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $236.00K 10-Q · filed 2013-08-06 | $236.53K 10-Q · filed 2012-08-14 | $675.95K 10-Q · filed 2012-08-14 | ||||||||||||||||
| 2012-03-31 | $236.00K 10-Q · filed 2013-05-09 | $236.53K 10-Q · filed 2012-05-15 | $675.95K 10-Q · filed 2012-05-15 | |||||||||||||||||
| 2011-12-31 | $439.00K 10-K · filed 2014-03-03 | $439.42K 10-K · filed 2012-03-29 | $439.42K 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |